Provides a corporate update and announces a shareholder videoconference call. Ventripoint continues to execute on its strategy to expand commercialization of VMS+â„¢, strengthen clinical adoption, and position the Company for revenue growth. Ventripoint Diagnostics Ltd shares V.VPT are trading off $0.01 at $0.11.
Full Press Release: https://www.baystreet.ca/quotedata/quote.aspx?ticker=VPT%3ACA&qmodStoryID=7284153015828700